Dechra Pharmaceuticals PLC
30 September 2005
Issued by Citigate Dewe Rogerson Limited, Birmingham
Date: Friday 30 September 2005
Immediate Release
Dechra Pharmaceuticals PLC
(the 'Company' or the 'Group')
Annual Information Update
The Report & Accounts for the year ended 30 June 2005 has been posted to
shareholders.
A copy of the Report and Accounts document has also been submitted to the UK
Listing Authority. Further copies are available on request from the Company
Secretary, Dechra Pharmaceuticals PLC, Dechra House, Jamage Industrial Estate,
Talke Pits, Stoke-on-Trent, ST7 1XW or from the Group web-site (www.dechra.com).
Under the new rules introduced on 1 July 2005 relating to Prospectus Directives
by the UKLA companies are required to list all regulatory news announcements
issued by the Company in the twelve month period preceding the date that the
published Accounts are issued to shareholders.
Dechra Pharmaceuticals PLC wish to advise that the following Regulatory News
Announcements have been issued by the Company over the period from 1 October
2004 to 30 September 2005:
30 September 2005 Annual Information Update
26 September 2005 Holding(s) in Company
23 September 2005 Report & Accounts for the year-ended 30 June 2005
published
19 September 2005 Holding(s) in Company
16 September 2005 Holding(s) in Company
13 September 2005 Holding(s) in Company
8 September 2005 Holding(s) in Company
6 September 2005 Preliminary Results for the year-ended 30 June 2005
24 August 2005 Holding(s) in Company
22 August 2005 Notice of Results (Final)
9 August 2005 Holding(s) in Company
9 August 2005 Director/PDMR Shareholding
19 July 2005 Holding(s) in Company
8 July 2005 Holding(s) in Company
5 July 2005 Pre-Closed Period Update
17 June 2005 Director Shareholding
1 June 2005 Holding(s) in Company
18 April 2005 Holding(s) in Company
12 April 2005 Additional Listing
5 April 2005 Licenses acquisition (Vetivex)
1 March 2005 Interim Results for the six months ended 31 December 2003
21 February 2005 Holding(s) in Company
17 February 2005 Worldwide Marketing Agreement (with Belcher Pharmaceuticals)
9 February 2005 Pharmaceutical Product Update
7 February 2005 Holding(s) in Company
1 February 2005 Statement re: Joint Venture (Vetcom Open/CamDal)
28 January 2005 Notice of Results (Interim)
17 January 2005 Holding(s) in Company
12 January 2005 Trading Update
24 December 2004 Additional Listing
14 December 2004 Additional Listing
19 November 2004 Additional Listing
9 November 2004 Additional Listing
21 October 2004 AGM Statement
12 October 2004 Additional Listing
Further details on the information contained within the above RNS announcements
can be viewed on the London Stock Exchange website: www.londonstockexchange.com
under code: DPH.
Enquiries:
Steve Whitehouse, Company Secretary Dechra Pharmaceuticals PLC Tel: +44 (0) 1782 771100
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.